Pulse Explorar nav.journalClub Debates Tendencias Investigadores Revistas

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

Thromboembolic Events in the South African Ad26.COV2.S Vaccine Study | Synapse

June 2, 2021Open Access

Ver artículo completo

Thromboembolic Events in the South African Ad26.COV2.S Vaccine Study

STSimbarashe TakuvaUniversity of the Witwatersrand ATAzwidihwi TakalaniUniversity of the Witwatersrand NGNigel GarrettNational Health Laboratory Service

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Rare Thromboembolic Events among Vaccinated South Africans Among 288,368 South African health care workers who received the Ad26.COV2.S vaccine, no cases of vaccine-induced immune thrombotic thromb...

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Takuva et al. (Wed,) studied this question.

synapsesocial.com/papers/6a62239f5aedc878c5f56542 https://doi.org/https://doi.org/10.1056/nejmc2107920

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination2021 · 2,282 citations
2Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination2021 · 997 citations
3High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review2019 · 175 citations
4Incidence and clinical significance of anti‐PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin‐induced thrombocytopenia2006 · 168 citations
5A Spontaneous Prothrombotic Disorder Resembling Heparin-induced Thrombocytopenia2008 · 170 citations